Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Rana

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Cancer Letters|February 18, 2026
MAP4K4 Regulates the Immune Landscape of Pancreatic Tumor Microenvironment and Provides an Opportunity for ImmunotherapySunil Kumar Singh, Sandeep Kumar, Saket Jha, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2012
Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular functionVelusamy Rangasamy, Rajakishore Mishra, Gautam Sondarva, et al.
The Journal of Biological Chemistry|August 15, 2013
The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinaseNavin Viswakarma, Yuzhi Jia, Liang Bai, et al.
Oncogene|June 10, 2024
MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathwayRong Ke, Navin Viswakarma, Mary Menhart, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2020
Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicitySandeep Kumar, Sunil Kumar Singh, Navin Viswakarma, et al.
Journal of Muscle Research and Cell Motility|March 14, 2026
Resistance-based exercise restores muscle health in dialysis patientsPiush Srivastava, Sunil Kumar Singh, Rakesh Sathish Nair, et al.
Cancer Letters|May 30, 2021
Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer developmentNavin Viswakarma, Gautam Sondarva, Daniel R Principe, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Calcium channel blockers potentiate gemcitabine chemotherapy  in pancreatic cancerDaniel R Principe, Alexandre F Aissa, Sandeep Kumar, et al.
Oncogene|February 22, 2023
TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancerRakesh Sathish Nair, Sandeep Kumar, Subhasis Das, et al.
Oncogene|September 13, 2021
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3Sunil Kumar Singh, Sandeep Kumar, Navin Viswakarma, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Cancer Letters|February 18, 2026
MAP4K4 Regulates the Immune Landscape of Pancreatic Tumor Microenvironment and Provides an Opportunity for ImmunotherapySunil Kumar Singh, Sandeep Kumar, Saket Jha, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2012
Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular functionVelusamy Rangasamy, Rajakishore Mishra, Gautam Sondarva, et al.
The Journal of Biological Chemistry|August 15, 2013
The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinaseNavin Viswakarma, Yuzhi Jia, Liang Bai, et al.
Oncogene|June 10, 2024
MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathwayRong Ke, Navin Viswakarma, Mary Menhart, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2020
Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicitySandeep Kumar, Sunil Kumar Singh, Navin Viswakarma, et al.
Journal of Muscle Research and Cell Motility|March 14, 2026
Resistance-based exercise restores muscle health in dialysis patientsPiush Srivastava, Sunil Kumar Singh, Rakesh Sathish Nair, et al.
Cancer Letters|May 30, 2021
Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer developmentNavin Viswakarma, Gautam Sondarva, Daniel R Principe, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Calcium channel blockers potentiate gemcitabine chemotherapy  in pancreatic cancerDaniel R Principe, Alexandre F Aissa, Sandeep Kumar, et al.
Oncogene|February 22, 2023
TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancerRakesh Sathish Nair, Sandeep Kumar, Subhasis Das, et al.
Oncogene|September 13, 2021
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3Sunil Kumar Singh, Sandeep Kumar, Navin Viswakarma, et al.
Pageof 12